SOPHiA GENETICS (SOPH) Net Income towards Common Stockholders (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Net Income towards Common Stockholders data on file, last reported at -$19.2 million in Q4 2025.

• For the quarter ending Q4 2025, Net Income towards Common Stockholders fell 26.53% year-over-year to -$19.2 million; the trailing twelve-month figure through Dec 2025 stood at -$34.2 million (down 6.43% YoY), and the FY2025 full-year result was -$79.0 million, down 26.41% from the prior year.
• Net Income towards Common Stockholders grew to -$19.2 million in Q4 2025, from -$20.0 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $24.7 million in Q2 2022 to a low of -$25.5 million in Q1 2022.
• A 5-year average of -$10.7 million and a median of -$17.9 million in 2021 frame the typical range for Net Income towards Common Stockholders.
• Across the five-year window, Net Income towards Common Stockholders tumbled 303.93% in 2021 and soared 234.21% in 2022, its largest moves.
• Tracing SOPH's Net Income towards Common Stockholders over 5 years: stood at -$21.4 million in 2021, then soared by 34.64% to -$14.0 million in 2022, then plunged by 72.21% to -$24.1 million in 2023, then soared by 37.0% to -$15.2 million in 2024, then decreased by 26.53% to -$19.2 million in 2025.
• Business Quant data shows SOPH's Net Income towards Common Stockholders at -$19.2 million in Q4 2025, -$20.0 million in Q3 2025, and $22.4 million in Q2 2025.